Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A Burger

Showing results (11-20 of 223) with videos related to

Pageof 23
Sort By:
Leukemia Research|January 20, 2007
No cell is an island unto itself: the stromal microenvironment in chronic lymphocytic leukemiaJan A Burger
Blood|January 9, 2016
Obinutuzumab: the more the merrier?Jan A Burger
Blood|April 12, 2012
BRAF mutation: supporting diversity in HCLJan A Burger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2019
Going through Changes: Surface IgM Levels during CLL Therapy with IbrutinibJan A Burger
Clinical Advances in Hematology & Oncology : H&O|May 12, 2016
Targeted Agents for the Frontline Management of Chronic Lymphocytic LeukemiaJan A Burger
Expert Opinion on Medical Diagnostics|March 14, 2013
The times they are a-changin': prognostic markers in the new era of BCR-targeting therapies for CLLJan A Burger
Leukemia Research|December 19, 2008
CXCR4 in acute myelogenous leukemia (AML): when too much attraction is bad for youJan A Burger
Current Hematologic Malignancy Reports|November 23, 2011
Inhibiting B-cell receptor signaling pathways in chronic lymphocytic leukemiaJan A Burger
Advances in Experimental Medicine and Biology|September 10, 2013
The CLL cell microenvironmentJan A Burger
Current Opinion in Oncology|September 11, 2012
Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscapeJan A Burger
Pageof 23

Showing results (11-20 of 223) with videos related to

Sort By:
Pageof 23
Leukemia Research|January 20, 2007
No cell is an island unto itself: the stromal microenvironment in chronic lymphocytic leukemiaJan A Burger
Blood|January 9, 2016
Obinutuzumab: the more the merrier?Jan A Burger
Blood|April 12, 2012
BRAF mutation: supporting diversity in HCLJan A Burger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2019
Going through Changes: Surface IgM Levels during CLL Therapy with IbrutinibJan A Burger
Clinical Advances in Hematology & Oncology : H&O|May 12, 2016
Targeted Agents for the Frontline Management of Chronic Lymphocytic LeukemiaJan A Burger
Expert Opinion on Medical Diagnostics|March 14, 2013
The times they are a-changin': prognostic markers in the new era of BCR-targeting therapies for CLLJan A Burger
Leukemia Research|December 19, 2008
CXCR4 in acute myelogenous leukemia (AML): when too much attraction is bad for youJan A Burger
Current Hematologic Malignancy Reports|November 23, 2011
Inhibiting B-cell receptor signaling pathways in chronic lymphocytic leukemiaJan A Burger
Advances in Experimental Medicine and Biology|September 10, 2013
The CLL cell microenvironmentJan A Burger
Current Opinion in Oncology|September 11, 2012
Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscapeJan A Burger
Pageof 23